Gynecology
Public education campaign launched on uterine fibroid embolization treatment
Published in Women's Health Weekly, April 4th, 2002
While two-thirds of American women (66%) are generally knowledgeable about uterine fibroids, the benign tumors that are one of the most common medical conditions experienced by women ages 35-50 and a leading cause of hysterectomy, only 1% of those women know about one of the most significant developments in the treatment of uterine fibroids, according to results of a national survey of women released by the Society of Cardiovascular and Interventional Radiology (SCVIR).
This treatment, called uterine fibroid embolization (UFE), gives women an important, minimally invasive treatment option to hysterectomy and other invasive surgeries, with less risk and less pain.
...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
More Articles from Women's Health Weekly
- Acute Myocardial Infarction
Mayo Clinic study finds heart disease burden shifting toward women, elderly - Obstetrics
Study boosts suspected link between mothers' gum disease and premature birth, low birth weight - Breast Cancer
Nonsurgical lumpectomy technique under investigation at UC Davis Cancer Center - Ovarian Cancer
Ethnicity influences survival - Thrombosis
Hormone replacement therapy exacerbates genetic risk factors - Vaginal Candidiasis
Novel peptide may possess antifungal activity - More from this issue of Women's Health Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
